See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Jerome Powell
Federal Reserve
Donald Trump
Senate
Social Media
Artificial Intelligence
Natural Disasters
Floods
Bitcoin
Education
Money
Cryptocurrency
pharmafile.com image

News from pharmafile.com

Information about pharmafile.com

Where is pharmafile.com located?pharmafile.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top pharmafile.com News

Swissmedic Approves Coartem Baby as First Malaria Treatment for Newborns
Vaccinations · Switzerland

Swissmedic Approves Coartem Baby as First Malaria Treatment for Newborns

65% Center coverage: 68 sources
See the Story
UV Safety Month: Raising Awareness of Skin Cancer Risks
Influencers

UV Safety Month: Raising Awareness of Skin Cancer Risks

64% Center coverage: 11 sources
July is UV Safety Awareness Month, and medical experts say that if you do not take precautions, you can still get a sunburn even when the sky is not clear.See the Story
Scientists Use AI to Create Protein that Kills E. Coli
Demis Hassabis

Scientists Use AI to Create Protein that Kills E. Coli

50% Center coverage: 6 sources
In the last year, there has been a surge in proteins developed by AI that will eventually be used in the treatment of everything from snakebites to cancer. What would normally take decades for a scientist to create—a custom-made protein for a particular disease—can now be done in seconds.See the Story

Moderna’s Latest Approval Again Reveals FDA Rift over COVID Vaccines

67% Right coverage: 3 sources
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.Vaccines · United StatesSee the Story

First UK Patients Receive Diabetes Drug That Delays Symptoms by Years

34% Center coverage: 6 sources
For more than a century, type 1 diabetes has meant one thing: a lifetime administering insulin.DiabetesSee the Story

Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth - Pharmafile

Jazz Pharmaceuticals has named Renée Galá as its next chief executive officer (CEO), effective 11 August 2025. Galá, currently president and chief operating officer (COO), succeeds co-founder Bruce Cozadd, who will retire as CEO and continue as chairperson of the board. The appointment follows a thorough succession process led by the board. Galá brings more […] The post Jazz Pharmaceuticals appoints Renée Galá as CEO to lead next phase of growth…Read Article

Osivax publishes positive results from trial of influenza vaccine candidate - Pharmafile

French biopharma, Osivax, has announced positive results from its phase 2 study, OVX836-004, into OVX836, its broad-spectrum influenza vaccine lead candidate. The results have been published in the journal, Vaccines. In the study, 180 healthy adults aged 18 to 55 years were given either Fluarix Tetra  (hemagglutinin antigen-based inactivated influenza vaccine) with a placebo, Fluarix […] The post Osivax publishes positive results from trial of i…France · FranceRead Article

Pharvaris to report phase 3 data and submit New Drug Application - Pharmafile

Pharvaris has announced that its data from its phase 3 study of deucrictibant immediate-release capsules (IR) for the treatment of hereditary angioedema (HAE) attacks will now be released in the fourth quarter of 2025. Pending positive results, the company expects to submit a New Drug Application to the US Food and Drug Administration in the […] The post Pharvaris to report phase 3 data and submit New Drug Application appeared first on Pharmafil…United States · United StatesRead Article

VIVES Partners contributes to €84m funding for radiopharma company, Nuclidium - Pharmafile

VIVES Partners, the managing company of VIVES Funds, has announced that it will contribute to an €84m Series B financing for Swiss radiopharma company, Nuclidium. The company will use the funds to advance the development of its Copper-61/Copper-67 (61Cu/67Cu) theranostic pipeline, applicable to multiple oncology indications. The funding round was led by Kurma Growth Opportunities […] The post VIVES Partners contributes to €84m funding for radiop…Switzerland · SwitzerlandRead Article

Secarna and Vect-Horus collaborate to advance therapies for central nervous system disorders - Pharmafile

Secarna Pharmaceuticals and Vect-Horus have announced that the companies will collaborate to develop RNA-targeted therapeutics capable of crossing the blood-brain barrier (BBB) to address diseases of the central nervous system (CNS). This intends to create new treatments for neurodegenerative and other central nervous system disorders, and marks a milestone in both companies’ expansion in targeted […] The post Secarna and Vect-Horus collaborate …Bavaria · BavariaRead Article

BioMed X and Servier launch Europe’s first XSeed Labs to advance AI-powered antibody design - Pharmafile

BioMed X and Servier have announced the launch of Europe’s first XSeed Labs research project, located at the Spartners incubator in Paris-Saclay, France. The initiative, hosted within Servier’s research site and operated by BioLabs, will develop an AI-enabled platform for sterically-guided bispecific antibody design. The XSeed Labs model, pioneered by BioMed X, brings together scientists […] The post BioMed X and Servier launch Europe’s first XS…Paris, France · ParisRead Article

Breaking News Topics Related to pharmafile.com

NHS icon

NHS

Cancer icon

Cancer

England icon

England

United Kingdom icon

United Kingdom

Health icon

Health

France icon

France

Germany icon

Germany

United States icon

United States

Medical icon

Medical

News
For You
SearchBlindspotLocal